Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone with different TAP block adjuvant combinations after minimally invasive lower abdominal surgery
ChiCTR2300071199Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone, ropivacaine, dexmedetomidine and magnesium sulfate in postoperative pain (4 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Time from completion of nerve block to first analgesia pump press. Planned start May 2023; status: not yet recruiting.
02
Drugs
dexamethasoneropivacainedexmedetomidinemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300071199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071199.